Evidencias de la revascularización en el infarto agudo de miocardio

Revista Española de Cardiología Suplementos - Tập 11 - Trang 9-14 - 2011
Antonio Fernández-Ortiz1, Javier Jiménez-Candil2, Vicente Bodí3, José A. Barrabés4
1Servicio de Cardiología, Hospital Clínico San Carlos, Universidad Complutense, Madrid, España
2Servicio de Cardiología. Hospital Universitario de Salamanca. Salamanca. España
3Servicio de Cardiología, Hospital Clínico Universitario, Universidad de Valencia, INCLIVA, Valencia, España
4Servicio de Cardiología, Hospital Universitario Vall d’Hebron, Universidad Autónoma de Barcelona, Barcelona, España

Tài liệu tham khảo

Nallamothu, 2003, Percutaneous coronary intervention versus fibrinolytic therapy in acute myocardial infarction: is timing (almost) everything?, Am J Cardiol, 92, 824, 10.1016/S0002-9149(03)00891-9 Betriu, 2005, Comparison of mortality rates in acute myocardial infarction treated by percutaneous coronary intervention versus fibrinolysis, Am J Cardiol, 95, 100, 10.1016/j.amjcard.2004.08.069 Boersma, 2006, Does time matter? A pooled analysis of randomized clinical trials comparing primary percutaneous coronary intervention and in-hospital fibrinolysis in acute myocardial infarction patients, Eur Heart J, 27, 779, 10.1093/eurheartj/ehi810 Pinto, 2006, Hospital delays in reperfusion for ST-elevation myocardial infarction: implications when selecting a reperfusion strategy, Circulation, 114, 2019, 10.1161/CIRCULATIONAHA.106.638353 Van de Werf, 2009, Guía de práctica clínica de la Sociedad Europea de Cardiología (ESC). Manejo del infarto agudo de miocardio en pacientes con elevación persistente del segmento ST, Rev Esp Cardiol, 62 Tillet, 1933, The fibrinolytic activity of hemolytic steptococci, J Exp Med, 58, 485, 10.1084/jem.58.4.485 González-Ferrer, 2007, Trombolíticos, 39 Boersma, 1996, Early thrombolytic treatment in acute myocardial infarction: reappraisal of the golden hour, Lancet, 348, 771, 10.1016/S0140-6736(96)02514-7 Rosell-Ortiz, 2008, Tratamiento extrahospitalario y supervivencia al año de los pacientes con infarto agudo de miocardio con elevación de ST. Resultados del Proyecto para la Evaluación de la Fibrinólisis Extrahospitalaria (PEFEX), Rev Esp Cardiol, 61, 14, 10.1157/13114952 Westerhout, 2011, The influence of time from symptom onset and reperfusion strategy on 1-year survival in ST-elevation myocardial infarction: A pooled analysis of an early fibrinolytic strategy versus primary percutaneous coronary intervention from CAPTIM and WEST, Am Heart J, 161, 283, 10.1016/j.ahj.2010.10.033 1993, The effects of tissue plasminogen activator, streptokinase, or both on coronary-artery patency, ventricular function, and survival after acute myocardial infarction, N Engl J Med, 329, 1615, 10.1056/NEJM199311253292204 Keeley, 2003, Primary angioplasty versus intravenous thrombolytic therapy for acute myocardial infarction: a quantitative review of 23 randomised trials, Lancet, 361, 13, 10.1016/S0140-6736(03)12113-7 Widimsky, 2010, European Association for Percutaneous Cardiovascular Interventions. Reperfusion therapy for ST elevation acute myocardial infarction in Europe: description of the current situation in 30 countries, Eur Heart J, 31, 943, 10.1093/eurheartj/ehp492 Brodie, 1994, Six-month clinical and angiographic follow-up after direct angioplasty for acute myocardial infarction. Final results from the Primary Angioplasty Registry, Circulation, 90, 156, 10.1161/01.CIR.90.1.156 Stone, 2002, Comparison of angioplasty with stenting, with or without abciximab, in acute myocardial infarction, N Engl J Med, 346, 957, 10.1056/NEJMoa013404 Iijima, 2009, Stents liberadores de fármacos frente a stents convencionales en pacientes diabéticos con infarto agudo de miocardio con elevación del segmento ST: un análisis combinado de los datos de pacientes individuales de 7 ensayos aleatorizados, Rev Esp Cardiol, 62, 354, 10.1016/S0300-8932(09)70892-9 Vlaar, 2008, Cardiac death and reinfarction after 1 year in the Thrombus Aspiration during Percutaneous coronary intervention in Acute myocardial infarction Study (TAPAS): a 1-year follow-up study, Lancet, 371, 1915, 10.1016/S0140-6736(08)60833-8 Terkelsen, 2009, Primary PCI as the preferred reperfusion therapy in STEMI: it is a matter of time, Heart, 95, 362, 10.1136/hrt.2007.139493 Srinivas, 2009, Effect of physician volume on the relationship between hospital volume and mortality during primary angioplasty, J Am Coll Cardiol, 53, 574, 10.1016/j.jacc.2008.09.056 2006, Primary versus tenecteplase-facilitated percutaneous coronary intervention in patients with ST-segment elevation acute myocardial infarction (ASSENT-4 PCI): randomised trial, Lancet, 367, 569, 10.1016/S0140-6736(06)68147-6 Ellis, 2008, Facilitated PCI in patients with ST-elevation myocardial infarction, N Engl J Med, 358, 2205, 10.1056/NEJMoa0706816 Ndrepepa, 2008, Prognostic significance of epicardial blood flow before and after percutaneous coronary intervention in patients with acute coronary syndromes, J Am Coll Cardiol, 52, 512, 10.1016/j.jacc.2008.05.009 Carver, 2009, Longer-term follow-up of patients recruited to the REACT (Rescue Angioplasty Versus Conservative Treatment or Repeat Thrombolysis) trial, J Am Coll Cardiol, 54, 118, 10.1016/j.jacc.2009.03.050 Ndrepepa, 2009, The only better alternative to rescue percutaneous coronary intervention is primary percutaneous coronary intervention, J Am Coll Cardiol, 54, 127, 10.1016/j.jacc.2009.03.045 Di Mario, 2008, Immediate angioplasty versus standard therapy with rescue angioplasty after thrombolysis in the Combined Abciximab REteplase Stent Study in Acute Myocardial Infarction (CARESS-in-AMI): an open, prospective, randomised, multicentre trial, Lancet, 371, 559, 10.1016/S0140-6736(08)60268-8 Le May, 2005, Combined angioplasty and pharmacological intervention versus thrombolysis alone in acute myocardial infarction (CAPITAL AMI study), J Am Coll Cardiol, 46, 417, 10.1016/j.jacc.2005.04.042 Fernandez-Avilés, 2004, Routine invasive strategy within 24 hours of thrombolysis versus ischaemia-guided conservative approach for acute myocardial infarction with ST-segment elevation (GRACIA-1): a randomised controlled trial, Lancet, 364, 1045, 10.1016/S0140-6736(04)17059-1 Danchin, 2008, Circulation, 118, 268, 10.1161/CIRCULATIONAHA.107.762765 Bodí, 2011, Resultados de la estrategia farmacoinvasiva y de la angioplastia primaria en la reperfusión del infarto con elevación del segmento ST. Estudio con resonancia magnética cardiaca en la primera semana y en el sexto mes, Rev Esp Cardiol, 64, 111, 10.1016/j.recesp.2010.10.008 De Luca, 2003, Symptom-onset-to-balloon time and mortality in patients with acute myocardial infarction treated by primary angioplasty, J Am Coll Cardiol, 42, 991, 10.1016/S0735-1097(03)00919-7 Nallamothu, 2007, Relationship of treatment delays and mortality in patients undergoing fibrinolysis and primary percutaneous coronary intervention. The Global Registry of Acute Coronary Events, Heart, 93, 1552, 10.1136/hrt.2006.112847 Sørensen, 2011, Urban and rural implementation of pre-hospital diagnosis and direct referral for primary percutaneous coronary intervention in patients with acute ST-elevation myocardial infarction, Eur Heart J, 32, 430, 10.1093/eurheartj/ehq437 Schiele, 2010, Reperfusion strategy in Europe: temporal trends in performance measures for reperfusion therapy in ST-elevation myocardial infarction, Eur Heart J, 31, 2614, 10.1093/eurheartj/ehq305